AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Sergiglid M XR60 Tablet

Prescription Icon
Prescription Required

Marketer

Sergio Remedies Pvt Ltd

Salt Composition

Gliclazide (60mg) + Metformin (500mg)

Overview Sergiglid M XR60 Tablet

Diabex Duo XR60, a dual-action antidiabetic medication, manages type 2 diabetes in adults. This combined formulation regulates blood glucose. Always take Diabex Duo XR60 with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled glucose levels; abrupt cessation can elevate blood sugar, risking complications such as nephropathy, retinopathy, neuropathy, and limb loss. Remember, it's one component of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Common side effects include hypoglycemia (low blood sugar – symptoms include sweating, dizziness, headache, and tremors), constipation, and nausea. Learn to recognize and treat hypoglycemia; maintain regular mealtimes and carry a fast-acting glucose source. Alcohol consumption should be limited due to increased hypoglycemia risk. Less frequent side effects might include altered taste, diarrhea, abdominal discomfort, and upper respiratory infections; weight gain is also possible. Diabex Duo XR60 is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease before commencing treatment. Pregnant or lactating individuals should consult their physician prior to use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Uses of Sergiglid M XR60 Tablet

Adult-onset diabetes

Major Benefits of Sergiglid M XR60 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and timeframe. Ingest the Sergiglid M XR60 Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

Common Side effects of Sergiglid M XR60 Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Sergiglid M XR60 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or breaking it. It's recommended to take Sergiglid M XR60 Tablet with food.

How Sergiglid M XR60 Tablet works:

Gliclazide and metformin are combined in Sergiglid M XR60, an extended-release tablet for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sergiglid M XR60 Tablet and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Sergiglid M XR60 Tablet is contraindicated during pregnancy due to confirmed risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Sergiglid M 60mg tablets are likely unsuitable for breastfeeding mothers. Available human evidence indicates potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Sergiglid M XR60 Tablet cautiously, potentially requiring dose modification. A physician's consultation is essential. This medication is contraindicated in patients with severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Sergiglid M XR60 Tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation with a low dose is typical; however, its use is contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Sergiglid M XR60 Tablet :

Should you forget a Sergiglid M XR60 Tablet dose, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Sergiglid M XR60 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sergiglid M XR60 Tablet

Sergiglid M XR60 Tablet combines gliclazide and metformin to manage type 2 diabetes mellitus (DM) in adults. It enhances blood glucose control when used with diet and exercise. Gliclazide boosts insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 DM.
Sergiglid M XR60 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Sergiglid M XR60 Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Sergiglid M XR60 Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect is more likely in patients with kidney disease, older individuals, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sergiglid M XR60 Tablets and seek immediate medical attention.
Prolonged use of Sergiglid M XR60 Tablets can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 is recommended at least annually by some researchers.
Sergiglid M XR60 Tablets are contraindicated in patients with known allergies to any ingredient or excipient. They should also not be used by those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Sergiglid M XR60 Tablet and alcohol is unsafe. This combination can dangerously lower blood sugar and raise the risk of lactic acidosis.
Sergiglid M XR60 Tablet combines gliclazide and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood sugar control when used with a healthy diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Sergiglid M XR60 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Sergiglid M XR60 Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases if you skip meals, drink alcohol, overexert yourself, or take other diabetes medications concurrently. Regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
Sergiglid M XR60 Tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). While rare, this side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Prolonged use of Sergiglid M XR60 Tablets can lead to vitamin B12 deficiency by interfering with its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sergiglid M XR60 Tablets are contraindicated in patients with known allergies to any ingredient or excipient. Their use is also contraindicated in patients with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining alcohol and Sergiglid M XR60 Tablet is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Sergiglid M XR60 Tablet
117
MRP 142
17% off